Daewoong Pharmaceutical Conducts Fair Trade Compliance Program Training

Daewoong Pharmaceutical announced on the 7th that it conducted a Fair Trade Compliance Program (CP) training both online and offline on the 3rd at its headquarters Bear Hall in Gangnam-gu, Seoul, targeting all employees engaged in sales and related duties for the second half of 2023.

On the 3rd, a Compliance Program (CP) training on fair trade was held at the Bear Hall of Daewoong Pharmaceutical headquarters in Gangnam-gu, Seoul.
[Photo by Daewoong Pharmaceutical]

The training, led by attorney Shin Ki-hyun of Wins Law Firm, was themed "Compliance Issue Review for Establishing a Proper Internal Compliance Culture" and covered ▲ characteristics of the pharmaceutical industry from a legal perspective ▲ rebate regulations and eradication measures ▲ major issues such as the CSO (Contract Sales Organization) reporting system and expenditure report preparation obligations following the amendment of the Pharmaceutical Affairs Act.

In particular, the training emphasized the interpretation and compliance methods of the Fair Competition Agreement and the procedures for preparing expenditure reports. These contents are expected to serve as key guidelines for Daewoong Pharmaceutical employees' future sales and marketing activities.

Lee Chang-jae, CEO of Daewoong Pharmaceutical, stated, “Daewoong Pharmaceutical conducts CP training regularly every year to ensure transparent and fair corporate activities. Besides the training, we share the purpose of ethical management and the company’s direction through various methods, and through this, all employees will continuously practice compliance management with a strong commitment.”

This content was produced with the assistance of AI translation services.